Naoyuki Hasebe Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

8/2012	[Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis].
5/2011	Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoyuki Hasebe Research Topics

Disease

18	Hypertension (High Blood Pressure) 12/2023 - 01/2003
10	Myocardial Infarction 05/2024 - 06/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2016 - 01/2004
7	Ischemia 04/2023 - 02/2006
7	Heart Failure 01/2020 - 03/2003
7	Proteinuria 12/2019 - 01/2003
6	Fibrosis (Cirrhosis) 01/2024 - 01/2006
6	Chronic Renal Insufficiency 01/2018 - 01/2006
6	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2015 - 10/2003
6	Ventricular Fibrillation 11/2014 - 01/2009
5	Atrial Fibrillation 12/2023 - 07/2008
5	Inflammation (Inflammations) 01/2019 - 05/2009
5	Myocardial Ischemia (Ischemic Heart Diseases) 03/2013 - 02/2006
5	Atherosclerosis 09/2011 - 01/2004
4	Brugada Syndrome 01/2018 - 01/2009
4	Cardiac Arrhythmias (Arrythmia) 01/2017 - 06/2002
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 08/2006
4	Essential Hypertension 01/2014 - 02/2005
4	Left Ventricular Dysfunction 04/2012 - 12/2004
3	Cardiomyopathies (Cardiomyopathy) 11/2019 - 10/2003
3	Diabetes Mellitus 01/2018 - 01/2004
3	Vascular Remodeling 01/2018 - 03/2010
3	Infarction (Infarctions) 01/2012 - 06/2002
3	Heart Diseases (Heart Disease) 07/2009 - 05/2005
3	Insulin Resistance 08/2006 - 09/2003
2	Acute Coronary Syndrome 05/2024 - 11/2011
2	ST Elevation Myocardial Infarction 05/2024 - 01/2012
2	Body Weight (Weight, Body) 10/2021 - 05/2003
2	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 01/2013
2	Parkinson Disease (Parkinson's Disease) 10/2021 - 10/2020
2	Dementia (Dementias) 10/2021 - 10/2020
2	Ischemic Stroke 06/2021 - 12/2017
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2021 - 05/2014
2	Muscular Diseases (Myopathy) 04/2021 - 11/2019
2	Fabry Disease (Fabry's Disease) 09/2019 - 01/2011
2	Vascular Diseases (Vascular Disease) 09/2019 - 05/2010
2	Embolism (Embolus) 01/2019 - 06/2015
2	Disease Progression 01/2019 - 01/2013
2	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2018 - 01/2003
2	Neoplasms (Cancer) 01/2018 - 02/2015
2	Syncope (Fainting) 01/2018 - 01/2009
2	Rheumatoid Arthritis 06/2017 - 01/2013
2	Hypokalemia 12/2016 - 01/2003
2	Asthma (Bronchial Asthma) 12/2016 - 11/2014
2	Hematoma 10/2016 - 01/2010
2	Ventricular Tachycardia 08/2015 - 01/2015
2	Cicatrix (Scar) 08/2015 - 06/2015
2	Hypoxia (Hypoxemia) 01/2015 - 09/2011
2	Death (Near-Death Experience) 01/2015 - 01/2008
2	Renal Insufficiency (Renal Failure) 01/2015 - 01/2003
2	Sarcoidosis (Schaumann Disease) 06/2014 - 01/2013
2	Glomerulonephritis 05/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

10	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 11/2019 - 06/2002
7	iodofiltic acidIBA 12/2016 - 09/2003
6	Antihypertensive Agents (Antihypertensives)IBA 12/2023 - 01/2006
5	Messenger RNA (mRNA)IBA 01/2024 - 05/2003
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2010
5	GadoliniumIBA 03/2016 - 01/2011
5	Nifedipine (Adalat)FDA LinkGeneric 01/2015 - 02/2005
5	candesartanIBA 01/2015 - 01/2003
4	AnticoagulantsIBA 12/2023 - 06/2015
4	SteroidsIBA 12/2019 - 01/2012
4	pentadecanoic acidIBA 12/2016 - 01/2003
4	MagnesiumIBA 01/2015 - 06/2002
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2007 - 01/2003
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2005 - 01/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 11/2014
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2017 - 01/2013
3	Prednisolone (Predate)FDA LinkGeneric 06/2017 - 01/2013
3	C-Reactive ProteinIBA 12/2016 - 05/2009
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2015 - 03/2010
3	Angiotensin IIIBA 01/2014 - 03/2003
3	Angiotensin Receptor AntagonistsIBA 01/2013 - 01/2003
3	ProstaglandinsIBA 07/2012 - 06/2002
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2011 - 01/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2006 - 01/2006
2	HSP72 Heat-Shock ProteinsIBA 05/2024 - 11/2006
2	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 12/2023 - 06/2015
2	Phosphopyruvate Hydratase (Enolase)IBA 10/2021 - 10/2020
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2021 - 01/2021
2	SaltsIBA 01/2020 - 04/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 03/2003
2	pitavastatin (itavastatin)FDA Link 11/2019 - 11/2011
2	GalactosidasesIBA 09/2019 - 01/2011
2	EnzymesIBA 09/2019 - 09/2004
2	ChemokinesIBA 01/2019 - 07/2012
2	EndonucleasesIBA 01/2019 - 08/2016
2	Endothelins (Endothelin)IBA 01/2018 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 06/2017 - 01/2013
2	InterleukinsIBA 01/2017 - 01/2016
2	InflammasomesIBA 01/2017 - 01/2016
2	CytokinesIBA 01/2016 - 05/2009
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2015 - 03/2003

Therapy/Procedure

28	Therapeutics 12/2023 - 06/2002
10	Renal Dialysis (Hemodialysis) 07/2017 - 01/2008
2	Percutaneous Coronary Intervention 10/2016 - 01/2012
2	Stents 10/2016 - 01/2015
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2016 - 01/2010